STAT+: ALS patients support bill that could help patients with other rare diseases
WASHINGTON — A month after advisers to the Food and Drug Administration overwhelmingly voted against…
Category: Medicine
.jpg)
Breaking down House Speaker Mike Johnson’s health care plan
You’re reading the web edition of D.C. Diagnosis. Sign up here to receive this newsletter in your…
Discovery that chimpanzees go through menopause challenges ‘grandmother hypothesis’
Chimpanzees — they’re just like us. Female chimps, it turns out, go through menopause, and…
Listen: ESMO highlights, Roivant’s big deal, & biotech VC on the rise
How do cancer drugs work? What makes biotech stocks go up? And why are venture…
STAT+: Teladoc stock slides despite business growth, Medtronic CEO talks innovation
You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology…
What will it take to end health care worker burnout?
Long hours and high-pressure situations have long characterized the health care profession — but in…
Pfizer’s twice daily pill for obesity hopes to rival Wegovy and Mounjaro
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Pharmalittle: Eisai reports injectable version of Alzheimer’s drug as effective as IV; Pfizer says combo flu and Covid shot shows strong response
Hello, everyone, and how are you this morning? We are doing just fine, thank you,…
Opinion: Want to end historic health care strikes? Fix a broken, outdated reimbursement model
History was made this month as more than 75,000 workers staged the largest health care…
STAT+: The health care issue Democrats can’t solve: hospital reform
WASHINGTON — Democrats unilaterally drove major reforms to the health insurance and the pharmaceutical industries…
STAT+: Looking to retain billions, hospitals warn Medicare’s drug payment fix is ‘unlawful’
Hospitals are telling government officials it would be illegal to claw back $7.8 billion as…
STAT+: Oncologists more likely to provide low-value care after receiving pharma money, study finds
Oncologists were more likely to provide low-value cancer care after receiving money from pharmaceutical companies,…
STAT+: Under-the-skin injection of Eisai’s Leqembi is as effective as IV infusion, new Alzheimer’s data show
A version of the Alzheimer’s disease drug Leqembi that can be given with a simpler,…
STAT+: Europe takes steps to head off drug shortages, even as U.S. proposals stall
European drug regulators are updating regulations to stem drug shortages. Are there lessons for Americans?…
STAT+: Novartis claims Takeda is stonewalling efforts to review trade secrets taken by a former employee
Novartis has gone to court to gain access to Takeda Pharmaceutical documents over concerns that…
After Gaza tweet, firing of life sciences journal editor sparks freedom of speech concerns
Pioneering life sciences journal eLife finds itself at the center of a white-hot furor after…
STAT+: Boston Scientific’s drug-coated balloon may reduce risk of heart attack
A drug-coated balloon made by Boston Scientific reduced the risk of heart attack in patients…
Senate committee advances Biden’s NIH nominee Monica Bertagnolli
A Senate health panel on Wednesday voted to send President Biden’s nominee to lead the…
STAT+: Biogen’s tau-lowering drug slows cognitive decline in early study of Alzheimer’s disease
An experimental treatment for Alzheimer’s disease that removes a toxic protein called tau from brain…
‘We’re absolutely making it too hard’: The complexity of adult immunization delivery hinders vaccine uptake
Alison Buttenheim was floored by a sign she saw in her doctor’s office when she…
The XBI biotech index hit its lowest point since 2018. No one knows what comes next.
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Pharmalittle: Pharma likely to expand legal attacks on Medicare negotiations; CDC recommends rationing RSV drug
Good morning, everyone, and how are you today? We are doing just fine, thank you….
Opinion: Listen: Why don’t the rules of war protect health care workers and facilities in Gaza?
In just two weeks, the brutality of the Israel-Hamas conflict has shocked the world. But…
Giant sloths and woolly mammoths: Mining past creatures’ DNA for future antibiotics
PHILADELPHIA — Cesar de la Fuente believes the next breakthrough antibiotic might come from animals…
Why is maternity leave for doctors such a complete mess?
I was sitting in my car around 4 p.m. on a Friday, waiting in the…
WHO considers adding ‘noma,’ a rare childhood disease, to its list of neglected conditions
It’s a disease of children living in extreme poverty. Its cause is uncertain. So is…
STAT+: Medtronic CEO talks latest bets on diabetes, high blood pressure technology
As one of the largest and oldest medical device companies in the world, Medtronic has…
The cardiologist building digital tools to help colleagues stay on top of new research
Visit the website of cardiologist Ruey Hu, and you can scroll through his prolific scientific…
STAT+: Massachusetts biotechs seek to piggyback on weight loss drug boom
The state’s celebrated cluster of biotechs has hatched breakthrough medicines for everything from COVID and…
STAT+: A controversial new study examines traditional Chinese medicine’s potential cardiac benefits
A traditional Chinese medicine compound used for cardiac benefits might help reduce the incidence of…
AstraZeneca, maker of FluMist, seeks to allow at-home administration of vaccine
People eligible to use the only needle-free flu vaccine available in the United States may…
CDC recommends rationing of RSV shot due to shortages
The Centers for Disease Control and Prevention has recommended rationing an important monoclonal antibody product…
STAT+: With an old approach but new energy, ADCs take center stage as promising cancer treatments
MADRID — If you had to pinpoint one subject that stood out at this year’s…
Why AstraZeneca’s CEO is accusing British tabloids of ‘fake news’
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Pharmalittle: Pharma moves closer to a pricing deal with U.K.; FDA to review AstraZeneca request for self-administered flu vax
Rise and shine, everyone, another busy day is on the way. We can tell because…
STAT+: Startup launches with $245 million for twice yearly asthma treatment
A new biotech has raised $245 million to test a new asthma medication that could…
STAT+: ‘Missed opportunities’: Why a U.K. government plan to disclose financial ties between pharma and docs may fall short
Earlier this month, the U.K. government issued a proposal to gather information and opinions about…
STAT+: For Parkinson’s disease, advances spurred by Apple Watch offer a glimmer of hope
Since the Apple Watch was unveiled in 2014, it has been trumpeted not only as…
Opinion: Do dementia villages actually work? We just don’t know
Recently, dementia villages have gained popularity in Europe and Australia as an all-in-one solution to…
The official definition of infertility now includes LGBTQ+ and single people
Infertility has a new definition in the U.S. — one that could make a big…
Opinion: Insulin is increasingly affordable in the U.S. What about the rest of the world?
In March, Eli Lilly, Novo Nordisk, and Sanofi — the world’s three largest insulin manufacturers…
STAT+: Roivant’s CEO is a star, but even a blockbuster deal can’t escape biotech’s black hole
Roivant Sciences’ Matt Gline might be this year’s best biopharma CEO, and other thoughts about…
Maternal Covid-19 vaccination offers infants immunity for up to 6 months
The risks of severe neonatal morbidity, neonatal death, and admission to the neonatal intensive care…
STAT+: Results on Novartis prostate cancer therapy could expand its use
MADRID — Results presented Monday could expand the use of a Novartis therapy for metastatic…
STAT+: Data on AstraZeneca cancer drug allay safety concerns but treatment still faces questions
MADRID — Questions about one of AstraZeneca’s key cancer drug candidates — and the dribs…
STAT+: In lung cancer, J&J data amount to latest salvo against AstraZeneca
MADRID — A competition has been brewing between two pharma titans — Johnson & Johnson…
Johnson & Johnson antiviral pill for dengue shows early efficacy
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Pharmalittle: Roche buys Roivant bowel disease drug for $7.1 billion; AstraZeneca CEO calls report of imminent retirement ‘fake news’
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT+: FDA clears Verve to begin U.S. study of gene-editing treatment for high cholesterol
Verve Therapeutics said Monday that it had received clearance from the Food and Drug Administration…
Fixing America’s health insurance woes is ‘actually very simple,’ says leading economist
Fixing the U.S. health care system can seem like a herculean task. But the solution…